Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

vet -

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

vet -

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

laboratorios karizoo -

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mylan healtcare gmbh - eprosartan; hidroklorotiazid - filmsko obložena tableta - eprosartan 600 mg / 1 tableta  hidroklorotiazid12,5 mg / 1 tableta; hidroklorotiazid 12,5 mg / 1 tableta - eprosartan in diuretiki

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mylan healtcare gmbh - eprosartan; hidroklorotiazid - filmsko obložena tableta - eprosartan 600 mg / 1 tableta  hidroklorotiazid12,5 mg / 1 tableta; hidroklorotiazid 12,5 mg / 1 tableta - eprosartan in diuretiki

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mylan healtcare gmbh - eprosartan, hidroklorotiazid - filmsko obložena tableta - eprosartan 600 mg / 1 tableta; hidroklorotiazid 12,5 mg / 1 tableta - eprosartan in diuretiki

Evropska unija - slovenščina - EMA (European Medicines Agency)

accord healthcare s.l.u. - fampridine - multiple skleroza - druga zdravila na živčnem sistemu - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).

Evropska unija - slovenščina - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriflunomide - multiplo sklerozo, recidivno-nakazila - imunosupresivi, selektivno imunosupresivi - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Evropska unija - slovenščina - EMA (European Medicines Agency)

accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - immunostimulants, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.

Evropska unija - slovenščina - EMA (European Medicines Agency)

le vet b.v. - prednizolon - kortikosteroidi za sistemsko zdravljenje, navaden, prednizolon, sistemsko hormonski preparati, razen. spolni hormoni in insulina - konji - zmanjševanje vnetnih in kliničnih parametrov, povezanih s ponavljajočo se obstrukcijo dihalnih poti (rao) pri konjih, v kombinaciji z nadzorom okolja.